NCT07456202 Menstrual Status, Anesthetic Consumption, and PONV
| NCT ID | NCT07456202 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Menstrual Cycle |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-03-07 |
| Primary Completion | 2026-05-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-03-07 with a primary completion date of 2026-05-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational cohort study aims to evaluate the association between menstrual phase (determined by postoperative serum progesterone levels), intraoperative anesthetic consumption, and the incidence and severity of postoperative nausea and vomiting (PONV) in female patients undergoing cholecystectomy. Intraoperative anesthetic requirements will be recorded, and postoperative nausea and vomiting will be assessed using standardized scoring systems.
Eligibility Criteria
Inclusion Criteria: * Female patients aged 18 to 65 years * American Society of Anesthesiologists (ASA) physical status I-II-III * Scheduled for elective laparoscopic cholecystectomy under general anesthesia * Willing and able to provide written informed consent Exclusion Criteria: * Age outside the specified range (younger than 18 or older than 65 years) * Male patients * American Society of Anesthesiologists (ASA) physical status ≥ IV * Severe systemic comorbidities (e.g., significant cardiovascular, hepatic, renal, or pulmonary disease) * Conversion from laparoscopic to open cholecystectomy * History of alcohol, drug, or substance abuse * Visual or hearing impairment interfering with study assessments * Current hormone replacement therapy * Use of oral contraceptives * Preoperative nausea or vomiting * History of severe postoperative nausea and vomiting * Neurological or psychiatric disorders affecting assessment reliability * Hemodynamic instability during surgery * Postoperative admission to intensive care unit * Acute cholecystitis at the time of surgery * Refusal to participate or inability to provide informed consent
Contact & Investigator
oya çimen, Specialist in Anesthesiology
PRINCIPAL INVESTIGATOR
Ankara Etlik City Hospital
Frequently Asked Questions
Who can join the NCT07456202 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Menstrual Cycle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07456202 currently recruiting?
Yes, NCT07456202 is actively recruiting participants. Contact the research team at oya.cimen@hotmail.com for enrollment information.
Where is the NCT07456202 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07456202 clinical trial?
NCT07456202 is sponsored by Ankara Etlik City Hospital. The principal investigator is oya çimen, Specialist in Anesthesiology at Ankara Etlik City Hospital. The trial plans to enroll 120 participants.